Delivery Order SPE2DE19D0010-SPE2D623F2N01

Award Date 3/28/23
Potential Completion Date 3/31/23
Potential Value $1.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Huntington Station, NY 11747, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,492.28 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc. for the provision of LOLLICAINE UNIDOSE TOPICAL GEL. The contract has an ultimate completion date of April 18, 2024. Henry Schein, Inc. is a global distributor of medical and dental supplies and has an extensive history of federal contract and subcontract awards, including Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs and Indian Health Service...
This is a delivery order under the Defense Logistics Agency's (DLA) Electronic Catalog (ECAT) II program, a $234.3 million multiple-award contract for dental products and consumables. The order, worth $1,170.41, was awarded to Henry Schein, Inc., a global medical and dental supply distributor, to provide Lidocaine Cartridge 2% with Epinephrine. This is a fixed-price contract with economic price adjustment, placed by the DLA's Medical Supply Chain division to support the Department of Defense and...
This federal contract award, identified as SPE2DE24D0026|SPE2D624F7CG0, was issued by the Medical Supply Chain, a defense-focused component of the Defense Logistics Agency (DLA), to Henry Schein, Inc., a global distributor of medical and dental supplies. The $2,442.00 fixed-price contract with economic price adjustment is for the delivery of LOLLICAINE UNIDOSE TOPICAL GEL, a topical anesthetic product, with a completion date of August 8, 2024. The contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract, valued at $1,218.54, is for the delivery of 4,564,140,420 units of Lollicaine Unidose Topical Gel. The contract does not have a set-aside designation and uses a fixed price with economic price adjustment pricing type. Henry Schein, Inc. is a large provider of healthcare products and services, with an extensive history of federal...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,963.60 to Henry Schein, Inc., a global medical and dental supply distributor, for the procurement of EQUIA FORTE HT dental restoration material refills. This contract is part of Henry Schein's larger $234.3 million Indefinite Delivery Contract (IDC) with the DLA's Electronic Catalog (ECAT) II program, which covers a wide range of dental products and consumables. The ECAT II contract supports the Department...
This federal contract award, with ID SPE2DE19D0010|SPE2D624F2QD7, was issued by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The award is for the delivery of 4565089233 - LIDOCAINE CARTRIDGE 2% W/EPI, a medical supply item, with a ceiling value of $4,308.00. The contract has a fixed price with economic price adjustment pricing type and a completion date of July 11, 2024. Henry Schein, Inc. is a for-profit organization and has an...
This delivery order, valued at approximately $305,000, was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Henry Schein, Inc. Enterprise Health / Federal Sales Division. The contract calls for Henry Schein to provide Lollicaine Unidose Topical Gel to DLA through August 17, 2023. Place of performance will be Henry Schein's facility in Huntington Station, New York. The fixed-price contract with economic price adjustment was awarded on August 3 and supports DLA's medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,488.34 Delivery Order contract to Henry Schein, Inc. Enterprise Health / Federal Sales Division for the supply of 4564459775 - LIDOCAINE HCL 2% 50S. This product is a local anesthetic pharmaceutical. The contract does not have a set-aside designation, indicating that Henry Schein competed in full and open competition. Henry Schein is a global medical and dental supply distributor that has an extensive history of providing a wide range of...
This is a fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global medical and dental supply distributor operating through its Usdg Federal Division. The contract, valued at $2,231.40, is for the delivery of Lidocaine Cartridge 2% with Epinephrine medical supplies. There is no set-aside designation, indicating full and open competition. The contract is part of Henry Schein's larger Indefinite Delivery Contract (IDC) with the DLA's...
This federal contract award, valued at $1,859.50, was issued by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract is for the delivery of 4566801340 LIDOCAINE CARTRIDGE 2% W/EPI, a pharmaceutical product, with a completion date of January 2, 2025. The award is not designated as a set-aside and represents a Delivery Order under a larger contract vehicle. Henry Schein, through its Enterprise Health / Federal Sales Division,...
  • SPE2DE19D0010
    Indefinite Delivery Contract
  • SPE2DE19D0010-SPE2D623F2N01
    Delivery Order

This contract award, with ID SPE2DE19D0010|SPE2D623F2N01, was issued by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global medical and dental supply distributor. The $1,933.96 fixed-price delivery order is for the supply of LOLLICAINE UNIDOSE TOPICAL GEL, a medical product. This award is part of Henry Schein's larger Indefinite Delivery Contract (IDC) with the DLA, specifically the Electronic Catalog (ECAT) II program, valued at $234.3 million with an ultimate completion date of July 15, 2029. The ECAT II contract covers a wide range of dental products and consumables to support the Department of Defense and other federal agencies. The current award has no set-aside designation, indicating full and open competition.

Generated 4/24/25, 10:58 AM